CVC shares rose about 3.3% on Friday, their best day since late April, after the firm co-launched a tender offer for Italian drugmaker Recordati.
CVC and Belgian investment firm Groupe Bruxelles Lambert launched a €10.7 billion cash bid to take Recordati private.
RBC analysts cited increased R&D needs and future M&A as rationale for the deal.












